Download
1 / 7
70 likes | 73 Vues
Global Pediatric Healthcare Industry was valued at USD 123.7 Billion in the year 2017. Global Pediatric Healthcare Industry is further estimated to grow at a CAGR of 3.8% from 2019 to reach USD 166.96 Billion by the year 2025. The North America region holds the highest Industry share in 2017 and the Asia Pacific is considered as the fastest growing Industry in the forecasted period. At a country level, US, China and the U.S. are projected to grow strongly in the coming years due to increasing density of population.
E N D
Pediatric Healthcare Industry Forecast and Size Analysis 2019-2025 Global Pediatric Healthcare Industry was valued at USD 123.7 Billion in the year 2017. Global Pediatric Healthcare Industry is further estimated to grow at a CAGR of 3.8% from 2019 to reach USD 166.96 Billion by the year 2025. The North America region holds the highest Industry share in 2017 and the Asia Pacific is considered as the fastest growing Industry in the forecasted period. At a country level, US, China and the U.S. are projected to grow strongly in the coming years due to increasing density of population. Major market players in Pediatric Healthcare Industry are Pfizer Inc., GlaxoSmithKline plc., Merck & Co. Inc, AstraZeneca plc., Boehringer Ingelheim GmbH, Gilead Sciences Inc., Sanofi S.A., Pediapharm Inc., Novartis AG, Eisai Co. Ltd., Mylan N.V., and brief overview of 9 companies is also provided in the report. Rising research and development expenses are catering to changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years. Request Sample Copy of this Market Research Report @ https://www.alexareports.com/report-sample/9222 SWOT Analysis of Pediatric Healthcare Industry: Strength: Changes in lifestyle Rising awareness towards pediatric disorders Weakness: High cost
Opportunities: Advancement in technology Threats: Inadequate regulatory funding The Drug Class segment is divided as Antibiotics, Analgesics, Antidepressants, Antidiarrheal, Antifungal, Anti-histamines, Anti-hypertensives, Anti-metabolites, Anti-neoplastic Antibiotics, Antipyschotics and Others in which the anti-biotics segment contributes to the highest share in the Industry. Antibiotics are extensively utilized, particularly for pediatric patients, due to their efficacy in treating bacterial infections. Pediatric Healthcare Industry Segmentation: By Drug Class • Antibiotics • Analgesics • Antidepressants • Antidiarrheal • Antifungal • Anti-histamines • Anti-hypertensives • Anti-metabolites • Anti-neoplastic Antibiotics • Antipyschotics • Others By Disorder/Disease • Allergy and Respiratory • Cancer
• Cardiovascular • Central Nervous System • Gastrointestinal • Hormonal Imbalance • Infections • Others Inquiry before Buying @ https://www.alexareports.com/send-an-enquiry/9222 By Services • Child Psychiatry Services • Gastrointestinal Services • Pediatric Cancer Services • Pediatric Diabetes Services • Pediatric Heart Services • Others By Region North America • USA • Canada Europe • Germany • U.K. • France
• Italy • Rest of Europe APAC • China • India • Japan • Rest of Asia-Pacific RoW • Latin America • Middle East & Africa Ask For Discount @ https://www.alexareports.com/check-discount/9222 Table of Content 1. Introduction 1.1 Industry Vision 1.1.1 Industry Definition 1.1.2 Industry Scope 1.2 Limitations 1.3 Stakeholders 8. Pediatric Healthcare Industry, By Services 8.1 Child Psychiatry Services 8.2 Gastrointestinal Services 8.3 Pediatric Cancer Services
8.4 Pediatric Diabetes Services 8.5 Pediatric Heart Services 8.6 Others 9 Geographical Analysis 9.1. Introduction 9.2. North America 9.2.1. U.S. 9.2.2. Canada 9.2.3. Mexico 9.3. Europe 9.3.1. Germany 9.3.2. France 9.3.3. U.K. 9.3.4. RoE 9.4. Asia Pacific 9.4.1. China 9.4.2. Japan 9.4.3. India 9.4.4. RoAPAC 9.5. RoW 9.5.1. Latin America 9.5.1.1. Brazil 9.5.1.2. Argentina 9.5.1.3. Rest of Latin America 9.5.2. Middle East and Africa
10. Company Profiles 10.1 Pfizer Inc., 10.1.1 Company Overview 10.1.2 Financial Overview 10.1.3 Product Overview 10.1.4 Current Development 10.2 GlaxoSmithKline Plc. 10.3 Merck & Co., Inc, 10.4 AstraZeneca Plc. 10.5 Boehringer Ingelheim GmbH, 10.6 Gilead Sciences, Inc., 10.7 Sanofi S.A., 10.8 Pediapharm, Inc. 10.9 Novartis AG, Eisai Co., Ltd., 10.10 Mylan N.V. 10. Competitive Analysis 10.1. Introduction 10.2. Industry Positioning of Key Players 10.3 Competitive Strategies Adopted by Leading Players 10.3.1. Investments & Expansions 10.3.2. New Product Launches 10.3.3. Mergers & Acquisitions 10.3.4. Agreements, Joint Ventures, and Partnerships 11. Appendix 11.1. Questionnaire
11.2. Available Customizations 11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences) Buy No @ https://www.alexareports.com/checkout/9222 About Us: Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data. Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data. Contact Us: Alexa Reports Ph no: +1-408-844-4624 / +91- 7030626939 Email: sales@alexareports.com Site: https://www.alexareports.com https://www.linkedin.com/company/alexa-report https://www.facebook.com/alexareportsinc https://twitter.com/Alexa_Reports
